Acasti pharma to present at q4 investor summit

Laval, quÉbec, nov. 09, 2022 (globe newswire) -- acasti pharma inc. (“acasti” or the “company”) (nasdaq: acst and tsx-v: acst), a late-stage, specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases, today announced that jan d'alvise, president and ceo of acasti pharma will be presenting virtually at the q4 investor summit. the company will be conducting a webcasted presentation and participating in one-on-one meetings with investors.
ACST Ratings Summary
ACST Quant Ranking